Macrophage CD5L is a target for cancer immunotherapy

BACKGROUND: Reprogramming of immunosuppressive tumor-associated macrophages (TAMs) presents an attractive therapeutic strategy in cancer. The aim of this study was to explore the role of macrophage CD5L protein in TAM activity and assess its potential as a therapeutic target. METHODS: Monoclonal ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Moral, Lidia, Paul, Tony, Martori, Clara, Font-Díaz, Joan, Sanjurjo, Lucía, Aran, Gemma, Téllez, Érica, Blanco, Julià, Carrillo, Jorge, Ito, Masaoki, Tuttolomondo, Martina, Ditzel, Henrik J., Fumagalli, Caterina, Tapia, Gustavo, Sidorova, Julia, Masnou, Helena, Fernández-Sanmartín, Marco-Antonio, Lozano, Juan-José, Vilaplana, Cristina, Rodriguez-Cortés, Alhelí, Armengol, Carolina, Valledor, Annabel F., Kremer, Leonor, Sarrias, Maria-Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139961/
https://www.ncbi.nlm.nih.gov/pubmed/37054630
http://dx.doi.org/10.1016/j.ebiom.2023.104555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139961/
https://www.ncbi.nlm.nih.gov/pubmed/37054630
http://dx.doi.org/10.1016/j.ebiom.2023.104555

Ejemplares similares